Overview of our Corporate News

October 11, 2018

Gerresheimer increases revenues by 8.8% and successfully integrates Sensile Medical

Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m Adjusted EBITDA at constant exchange rates—excluding Sensile Medical and...

October 11, 2018

Andreas Schütte steps down from Management Board of Gerresheimer AG

Duesseldorf, October 11, 2018—Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in...

September 27, 2018

Micro pump for Parkinson’s treatment from Gerresheimer subsidiary Sensile Medical receives European CE declaration of conformity

Duesseldorf/Olten, September 27, 2018 – A wearable micro pump from Sensile Medical has received EU certification for the European market. A European pharma...

September 06, 2018

Dietmar Siemssen appointed new CEO of Gerresheimer AG

Dietmar Siemssen to assume as Chief Executive Officer on November 1, 2018. Previously held position as Stabilus CEO. Speaker of the Management Board and CFO...

July 11, 2018

Ad Hoc: Gerresheimer acquires Sensile Medical / irrespective of that, increased growth and improved profitability expected mid-term due to two new major orders with temporarily higher capex / organic revenue guidance 2018 narrowed to upper end of range